Home Healthcare Drugs Europe Narcolepsy Market to 2027

Europe Narcolepsy Market to 2027

Publisher: The Insight Partners
Publication Date: January, 2020
Healthcare / Drugs
Pages: 123
Delivery Format: PDF

Regional Analysis and Forecasts By Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy); Product (Central Nervous System (CNS) Stimulants, Sodium Oxybate, and Antidepressants); Distribution Channel (Hospital Pharmacies and Retail Pharmacies) and Country

Report Features
Table of Contents
Pricing
Methodology
Request Sample
Compare Offers
Make an Offer

Europe, the narcolepsy market, is anticipated to reach US$ 1,532.5 Mn in 2027 from US$ 671.1 Mn in 2018. The market is projected to grow with a CAGR of 9.7% from 2019-2027.
The European narcolepsy market is expected to grow due to key driving factors such as growing research and developments and increasing awareness across the region. The market is divided into three countries such as the Germany, UK, France, Italy and Spain. In Europe, narcolepsy with cataplexy is a rare disease with an estimated prevalence of 0.02% in European populations. Narcolepsy shares many features of rare disorders, in particular the lack of awareness of the disease with serious consequences for healthcare supply. Similar to other rare diseases, only a few European countries have registered narcolepsy cases in databases of the International Classification of Diseases or in registries of the European health authorities.
Narcolepsy is a rare diseases which shows different symptoms in children and adults. The symptoms shown by children are not noticed that much until they reach adulthood. However, the incidences of narcolepsy in children are less and is not estimated due to the undiagnosed of the conditions. According to a study ‘Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy’ published in 2018 stated that the prevalence of the narcolepsy among children between the age 5 years and below is 13 per 100,000. Whereas, it 83 for every 100,000 children between the age group of 5 years and 19 years. Therefore, it is necessary to raise awareness among the people so to reduce the symptoms of narcolepsy.
Across, Europe the awareness is increasing significantly, For instance, in Ireland 22nd September is celebrated as narcolepsy day. Across the Ireland kite flying event was conducted, it displayed the about the narcolepsy. The event was successfully held and the aim to aware people about narcolepsy was fulfilled. Similarly in Italy in September 2016, University of Bologna in collaboration with Italian Narcolepsy Community conducted a narcolepsy awareness program that involved speakers from Italy, France and the US to talk about the novel findings and propagate general information to the populace regarding narcolepsy and other sleep related neurological disorders. Thus, it is estimated that the rising awareness program is likely to influence the growth of market during the forecast period.
The Europe narcolepsy market is segmented as type, product and distribution channels. Based on type the market is segmented as narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary narcolepsy. Based on the product the market is categorized as central nervous system (CNS) stimulants, sodium oxybate, and antidepressants. And based on distribution channel the market is classified as hospital pharmacies and retail pharmacies.
In 2018, the narcolepsy with cataplexy segment held a largest market share of the narcolepsy market, by type. This segment is expected to dominate the market in 2027 owing to the rising episodes of cataplexy that are expected to be encountered among 55-60% of patients suffering with narcolepsy. The segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.
Some of the significant primary and secondary sources for narcolepsy included in the report are European Commission, European Medicines Agency, European Union, Associazione Italiana di Medicina del Sonno and others.

Reasons to buy this report:
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe narcolepsy market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the Europe narcolepsy market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Select Plan

1 User License $3,000

Site License License $4,000

Are you looking for a Consultant?

Email Us

Get a Quote

Offer Amount (Per user license)	Retail price (Per user license)
$ .00	$3,000

Europe Narcolepsy Market to 2027

Are you looking for a Consultant?

Customers Who Viewed This Item Also Viewed